Skip to main content
Apollo Hospitals Enterprises Ltd. logo

Apollo Hospitals Enterprises Ltd. — Investor Relations & Filings

Ticker · APOLLOHOSP ISIN · INE437A01024 BSE.NS Human health and social work activities
Filings indexed 1,914 across all filing types
Latest filing 2024-04-25 Regulatory Filings
Country IN India
Listing BSE.NS APOLLOHOSP

About Apollo Hospitals Enterprises Ltd.

https://www.apollohospitals.com/

Apollo Hospitals Enterprises Ltd. is an integrated healthcare provider operating a vast network of multi-specialty hospitals, primary care facilities, and diagnostic centers. The organization offers specialized clinical services in fields such as cardiology, oncology, neurology, orthopedics, and multi-organ transplants. Its business model encompasses an extensive retail pharmacy chain and a digital health ecosystem, Apollo 24/7, providing teleconsultations and home-based care. The company leverages advanced medical infrastructure, including robotic surgery systems and proton therapy, to provide complex tertiary care. Serving both domestic and international patients, the company integrates preventive health screenings, emergency medical services, and clinical research. The focus remains on delivering comprehensive medical solutions through a vertically integrated model that spans from primary clinics to advanced quaternary care centers.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a communication from Apollo Hospitals Enterprise Limited to stock exchanges regarding the loss of share certificates by shareholders and the process for issuing duplicate certificates. It references Regulation 39(3) of the SEBI (LODR) Regulations, 2015, which pertains to share certificate loss and replacement. The content is an official notification about share certificate loss and related shareholder information, not a financial report, earnings release, or management discussion. It is not a report publication announcement or certification letter but a regulatory compliance notification. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-04-25 English
Annexure enclosed
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges regarding the loss of a share certificate by a shareholder, including details such as folio number, shareholder name, share certificate number, and distinctive numbers. It references Regulation 39(3) of SEBI (LODR) Regulations, which pertains to share certificate loss and related procedures. The document is an official intimation or announcement to the exchanges rather than a financial report, management discussion, or any other detailed corporate filing. It does not contain financial data, audit information, or meeting materials. It is a regulatory announcement about share certificate loss, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-04-16 English
Loss of Share Certificates
Regulatory Filings Classification · 90% confidence The document is extremely short (214 characters) and consists solely of a table listing shareholders and their shareholdings. There is no narrative, financial data, or report content. It appears to be a snippet of a shareholding register or a similar record. This does not match any detailed report or announcement categories such as Annual Report, Earnings Release, or Management Reports. It also does not contain any voting results, director dealings, or capital changes. Given the lack of context and the nature of the content, the best fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories.
2024-04-16 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which pertains to the yearly disclosure of promoter shareholding and encumbrance for the year ended 31st March 2024. It includes detailed tables of promoter shareholdings and encumbered shares. This type of document is a notification of changes or status in major shareholding levels by promoters, which fits the definition of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding. Therefore, the correct classification is MRQ with high confidence.
2024-04-10 English
Response to your mail dated 6th April 2024 as per annexure enclosed
AGM Information Classification · 100% confidence The document contains detailed information about the proceedings of the Annual General Meeting (AGM) held on 30th August 2023, including the summary of proceedings, voting results, and resolutions passed. It references compliance with SEBI regulations related to AGM disclosures and includes agenda items and voting outcomes. The content is focused on the AGM event itself rather than financial results or other report types. Therefore, the document is best classified as AGM Information (AGM-R).
2024-04-06 English
In response to the query raised by BSE on 3rd April 2024, the clarification provided by the company on corporate announcement submitted on 2nd April 2024 relating to change in directorate is enclosed
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the completion of tenure of an Independent Director, Mr. Vinayak Chatterjee, at Apollo Hospitals Enterprise Limited. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosures about changes in directors or key managerial personnel. The document includes details about the director's cessation, reasons for change, and subsequent board committee reconstitution. There is no financial data, earnings information, or report publication mentioned. The content is focused on management/board changes and regulatory compliance disclosures. Therefore, this document fits the category of Board/Management Information (MANG). The document length (9853 characters) and detailed disclosure support this classification with high confidence.
2024-04-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.